An Open Label Crossover Study In Healthy Older Male Subjects To Evaluate The Pharmacokinetics And Safety Of An Orally Disintegrating Tablet Formulation Of Sildenafil Administered Without Water Under Fed Compared To Fasted Conditions.

Trial Profile

An Open Label Crossover Study In Healthy Older Male Subjects To Evaluate The Pharmacokinetics And Safety Of An Orally Disintegrating Tablet Formulation Of Sildenafil Administered Without Water Under Fed Compared To Fasted Conditions.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2014

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 11 Jan 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Jan 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 13 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top